Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 9/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.53 |
| ▸ | RAB9A | P51151 | 8/20 | 0.53 |
| ▸ | TP53 | P04637 | 7/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.53 |
| ▸ | HPGD | P15428 | 6/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL834225 | 0.88 | HSD17B10 (0.54) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL834780 | 0.88 | HSD17B10 (0.57) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL834481 | 0.87 | SMN1; SMN2 (0.51) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL835365 | 0.87 | SMN1; SMN2 (0.51) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL834314 | 0.87 | NPC1 (0.56) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL834248 | 0.85 | HSD17B10 (0.57) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL834330 | 0.85 | NPC1 (0.59) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL834337 | 0.85 | NPC1 (0.59) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL829307 | 0.85 | NPC1 (0.59) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 | |
| SCHEMBL834835 | 0.85 | NPC1 (0.51) | NPC1HSD17B10RAB9ATP53SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9209408-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-12-08 | — | — | US | disclosed |
| US-9209408-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-12-08 | — | — | US | disclosed |
| US-20130261304-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-10-03 | — | — | US | disclosed |
| US-20130261304-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-10-03 | — | — | US | disclosed |
| US-8450485-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| US-8450485-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-07-12 | — | — | US | disclosed |
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-07-12 | — | — | US | disclosed |
| US-8142911-B2 | Organic compound, benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using the benzoxazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178933-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | NPC1 4201/4885HSD17B10 1425/4885RAB9A 3557/4885 |
| US-20090284142-A1 | Organic Compound, Benzoxazole Derivative, and Light-Emitting Element, light-Emitting Device, and Electronic Device Using the Benzoxazole Derivative | XDH, CYP2C9, CYP4X1 | NPC1 4220/4885HSD17B10 1670/4885RAB9A 3455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.